| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |